Announce Date | 04/28/2025 |
EPS Normalized Actual | $0.26 (Miss by $-0.05) |
EPS GAAP Actual | $0.26 (Miss by $-0.05) |
Revenue Actual | $0B |
Revenue Surprise | Beat by $0M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.20913 |
EPS GAAP Estimate | $1.20913 |
Revenue Estimate | $0.751686959B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 5.73 | 4.65 | 5.23905 | 6.04264 | 2 |
Dec 2026 | 7.89258 | 3.38 | 6.87517 | 8.91 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.73 | -0.4916 | 0B | -INF% | -767.62M |
FQ4 2024 (Dec 2024) | 0.5545 | 0.5545 | 0.927341B | 30.66% | 927.34M |
FQ3 2024 (Sep 2024) | 0 | 0 | 0.800549B | 12.88% | 800.55M |
FQ2 2024 (Jun 2024) | 0 | 0 | 0.692844B | 99.91% | 692.84M |
FQ1 2024 (Mar 2024) | 0 | 0 | 0.637084B | 3.93% | 637.08M |
FQ4 2023 (Dec 2023) | 1.06 | 1.06 | 0.642979B | 100% | 642.98M |
FQ3 2023 (Sep 2023) | 0 | 0 | 0.69745B | 100% | 697.45M |
FQ1 2021 (Mar 2021) | 0 | 0 | 0.281311B | 100% | 281.31M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.20913
Consensus Revenue Estimates
0.751686959B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0 | -- | 0 | 0 | 2 |
FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 2 |
FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 2 |
FQ4 2026 (Oct 2026) | 1.80895 | -- | 1.7651 | 1.87188 | 0 |
FQ3 2026 (Jul 2026) | 1.8003 | -- | 1.75666 | 1.86293 | 0 |
FQ2 2026 (Jun 2026) | 1.92773 | -- | 1.82037 | 2.04566 | 0 |
FQ1 2026 (Mar 2026) | 1.77322 | 58.83 | 1.67447 | 1.8817 | 0 |
FQ4 2025 (Oct 2025) | 1.3002 | 57.35 | 1.26868 | 1.34543 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.86B | -- | 0.82B | 0.9B | 4 |
FQ2 2027 (Jun 2027) | 0.83B | -- | 0.79B | 0.87B | 6 |
FQ1 2027 (Mar 2027) | 0.78B | -- | 0.74B | 0.81B | 4 |
FQ4 2026 (Oct 2026) | 1.18B | -- | 1.16B | 1.21B | 2 |
FQ3 2026 (Jul 2026) | 1.11B | -- | 1.09B | 1.14B | 2 |
FQ2 2026 (Jun 2026) | 2.25B | -- | 2.15B | 2.36B | 1 |
FQ1 2026 (Mar 2026) | 2.09B | -- | 2B | 2.19B | 1 |
FQ4 2025 (Oct 2025) | 0.77B | -20.75 | 0.75B | 0.79B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
1
EPS # of in-lines
5
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.2216 | 0.73 | -0.4916 | -67.34% |
FQ4 2024 (Dec 2024) | 0.5545 | 0.5545 | 100% | |
FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
FQ4 2023 (Dec 2023) | 1.06 | 1.06 | 100% | |
FQ3 2023 (Sep 2023) | 0 | 0 | NAN% | |
FQ1 2021 (Mar 2021) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.77B | $0B | $-767.62M | -INF% |
FQ4 2024 (Dec 2024) | $0B | $0.93B | $927.34M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.8B | $800.55M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.69B | $692.84M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.64B | $637.08M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.64B | $642.98M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.7B | $697.45M | 100% |
FQ1 2021 (Mar 2021) | $0B | $0.28B | $281.31M | 100% |